The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen- and progesterone-responsive endometrial cancer cell line

Journal of Molecular Endocrinology

Volumn 37, Issue 3, 2006, Pages 405-413

  Hanifi Moghaddam, P ^a   Sijmons, B ^a   Ott, M C ^b   van IJcken, W F J ^a   Nowzari, D ^a   Kuhne, E C M ^a   van der Spek, P ^a   Kloosterboer, H J ^c   Burger, C W ^a   Blok, L J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b OmniViz Inc   (United States)

^c Research and Development   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR; MEDROXYPROGESTERONE ACETATE; MINICHROMOSOME MAINTENANCE PROTEIN; PROGESTERONE RECEPTOR; TIBOLONE;

ARTICLE; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM CANCER; GENE EXPRESSION PROFILING; GENE REPLICATION; GENETIC TRANSFECTION; GROWTH INHIBITION; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL LINE, TUMOR; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONE REPLACEMENT THERAPY; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; NORPREGNENES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGESTERONE; TRANSCRIPTION, GENETIC;

EID: 33846142848     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.02057     Document Type: Article

References (22)

1. Anderson GL, Judd HL, Kaunitz AM, Barad DH, Beresford SA, Pettinger M, Liu J, McNeeley SG, Lopez AM & Women's Health Initiative Investigators 2003 Effects of estrogen plus progesrin on gynecologic cancers and associated diagnostic procedures: the women's health initiative randomized trial. Journal of the American Medical Association 290 1739-1748.
2. Bailis JM & Forsburg SL 2004 MCM proteins: DNA damage mutagenesis and repair. Current Opinion in Genetics and Development 14 17-21.
3. Beral V, Bull D & Reeves G 2005 Endometrial cancer and hormone-replacement therapy in the million women studx. Lancet 365 1543-1551.
4. Blok LJ, Grossmann ME, Perry JE & Tindall DJ 1995 Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation. Molecular Endocrinology 9 1610-1620.
5. Bolstad BM, Irizarry RA, Astrand M & Speed TP 2003 A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19 185-193.
6. de Gooyer ME, Oppers-Tiemissen HM, Leysen D, Verheul HA & Kloosterbper HJ 2003 Tibolone is not converted by human aromatase to 7alpha-nethyl-17alpha-ethynylestradiol (7alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS. Steroids 68 235-243.
7. Gielen SC, Hanekamp EE, Blok LJ, Huikeshoven FJ & Burger CW 2005 Steroid-modulated proliferation of human endometrial carcinoma cell lines: any role for insulin-like growth factor signaling? Journal of the Society for Gynecologic Investigation 12 58-64.
8. Guida T, Salvatore G, Faviana P, Giannini R, Garcia-Rostan G, Provitera L, Basolo F, Fusco A, Carlomagno F & Santoro M 2005 Mitogenic effects of the up-regulation of minichromosome maintenance proteins in anaplastic thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 90 4703-4709.
9. Hanifi-Moghaddam P, Gielen SC, Kloosterboer HJ, De Gooyer ME, Sijbers AM, van Gool AJ, Smid M, Moorhouse M, van Wilk FH, Burger CE et al. 2005 Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone. Journal of Clinical Endocrinology and Metabolism 90 973-983.
10. Kato K, Toki T, Shimizu M, Shiozawa T, Fujii S, Nikaido T & Konishi I 2003 Expression of replication-licensing factors MCM2 and MCM3 in normal, hyperplastic, and carcinomatous endometrium: correlation with expression of Ki-67 and estrogen and progesterone receptors. International Journal of Gynecological Pathology 22 334-340.
11. Klaassens AHA, Van Wijk FH, Hanifi-Moghaddam P, Sijmons B, Ewing PC, Ten Kate-Booij MJ, Kooi GS, Kloosterboer HJ, Blok LJ & Burger CW 2006 Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with fibolone, estrogen-only, or estrogen plus progestagen. Fertility and Sterility 86 352-361.
12. Kloosterboer HJ 2001 Tibolone: a steroid with a tissue-specific mode of action. Journal of Steroid Biochemistry and Molecular Biology 76 231-238.
13. Markiewicz L & Gurpide E 1990 In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium. Journal of Steroid Biochemistry and Molecular Biology 35 535-541.
14. Satvaswaroop PG, Zaino RJ & Mortel R 1983 Human endometrial adenocarcinoma transplanted into nude mice: growth regulation by estradiol. Science 219 58-60.
15. Schatz F, Kuczynski E, Kloosterboer HJ, Buchwalder L, Tang C, Krikun G & Lockwood CJ 2005 Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: evidence of progestagenic effects. Steroids 70 840-845.
16. Smid-Koopman E, Kuhne LC, Hanekamp EE, Gielen SC, De Ruiter PE, Grootegoed JA, Helmerhorst TJ, Burger CW, Brinkmann AO, Huikeshoven FJ et al. 2005 Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines. Journal of the Society for Gynecologic Investigation 12 285-292.
17. Steckelbroeck S, Jin Y, Oyesanmi B, Kloosterboer HJ & Penning TM 2004 Tibolone is metabolized by the 3alpha/3beta-hydroxysteroid dehydrogenase activities of the four human isozymes of the aldo-keto reductase 1C subfamily: inversion of stereospecificity with a delta5(10)-3-ketosteroid. Molecular Pharmacology 66 1702-1711.
18. Tang B, Markiewicz L, Kloosterboer HJ & Gurpide E 1993 Human endometrial 3 beta-hydroxysteroid dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroidal drug (Org OD 14). Journal of Steroid Biochemistry and Molecular Biology 45 345-351.
19. Taylor AH & Al-Azzawi F 2000 Immunolocalisation of oestrogen receptor beta in human tissues. Journal of Molecular Endocrinology 24 145-155.
20. Timmer CJ & Houwing NS 2002 Dose proportionality of three different doses of tibolone. Pharmacotherapy 22 6.
21. Tseng L & Gurpide E 1975 Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology 97 825-833.
22. Zhang H, Pan KH & Cohen SN 2003 Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci. PNAS 100 3251-3256.